The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis

By afschroeder • March 5, 2026

Kyan K, Gornbein J, Saver J. The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis. Front Cardiovasc Med. 2026 Feb 17;13:1769430. doi: 10.3389/fcvm.2026.1769430. PMID: 41783026; PMCID: PMC12954586.

Tags: Atherosclerosis, DOM STAT, General Internal Medicine, hyperlipidemia, LDL cholesterol, lipid lowering agent, PCSK9 inhibitors, Publications, Statins

Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and a Positive Scl-70 Antibody Test

Perini Villanueva G, Kokaly A, Sunku N, Chung CW. Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and[...]

Evaluating the accuracy of brief cognitive assessments for the early detection of cognitive impairment in adults across primary and specialty care settings: A systematic review and meta-analysis

Loveless J, Pilcher L, Bolton CJ, Guan DX, Imo U, Ngubo CGA, McAteer MB, Urquhart O, Rangarajan SK, Kim LS, Sako K, Tang B, Yakoub[...]

Effect of Electronic Behavioral Nudges on Low-Value Preoperative Testing: A Pragmatic Randomized Clinical Trial

Sarkisian CA, Villaflores CW, Vangala SS, Cheng EM, Shu SB, Goldstein NJ, Hofer IS, Duval VF, Bartlett JD, Moore JM, Pessegueiro AM, Skootsky SA, Damberg[...]